DEPARTMENT OF VETERANS AFFAIRS
Veterans Health Administration
Network Contracting Office 17 (NCO 17)
Lab Services Support (LSS)
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Pursuant to FAR 13.106-1(b) Soliciting from a Single Source
ADMINISTRATIVE DATA
Posting Date: June 24, 2026
Response Deadline: July 7, 2026 (10 calendar days from posting date)
Contracting Office: Department of Veterans Affairs, RPO West | NCO 17 | Lab Services Support (LSS)
Address: 5441 Babcock Rd., Suite 302, San Antonio, TX 78240
Contracting Officer: Ognian D. Ivanov, Contracting Officer
NAICS Code: 334516 Analytical Laboratory Instrument Manufacturing
Size Standard: $1,000 (receipts) | 1,250 employees
Intended Contractor: Agilent Technologies, Inc.
Contractor Address: 2850 Centerville Road, Wilmington, DE 19808
Contract Type: Firm Fixed Price (FFP) Purchase Order
Performance Period: One-Time Delivery As Soon As Possible (ASAP)
Place of Performance: VISN 17 Center of Excellence, 4800 Memorial Drive, Building 93, MRI W93, Waco, TX 76711
DESCRIPTION OF REQUIREMENT
The Department of Veterans Affairs (VA), Network Contracting Office 17 (NCO 17), on behalf of the VISN 17 Center of Excellence located in Waco, Texas, intends to award a Firm Fixed Price purchase order on a sole source basis to Agilent Technologies, Inc. for the acquisition of one (1) Agilent Seahorse XF Pro Analyzer (Stock No. S7855A / SYS-SE-XFPRO), to include software, consumables, and a 5-year extended warranty, in accordance with the authority cited below.
Items Required:
Stock Number
Item Description
Qty
S7855A
Seahorse XF Pro Analyzer
1
SYS-SE-XFPRO
XF Pro Cell Analyzer Real Time Metabolic Cell Analyzer
1
SOLE SOURCE AUTHORITY AND JUSTIFICATION
This acquisition is conducted under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b), Soliciting from a Single Source. The estimated value of this acquisition is below the simplified acquisition threshold. The VA has determined that only Agilent Technologies, Inc. can meet the Government's requirements based on the following:
1. Unique Technology The Agilent Seahorse XF Pro Analyzer is the only commercially available platform capable of simultaneously measuring both oxygen consumption rate (OCR) and proton efflux rate (PER) in live cells in real time using a sealed microchamber and solid-state fluorophore sensor cartridge design. No other manufacturer produces a functionally equivalent system.
2. Proprietary Software and Consumables The requirement includes Wave Pro Controller software, Seahorse Analytics platform, and integration with Agilent BioTek Cytation imaging systems all proprietary components exclusive to the Agilent Seahorse ecosystem. These cannot be sourced from alternative vendors.
3. Authorized Service Restriction Per the Statement of Work, only licensed Agilent Technologies technicians are authorized to install, service, and provide training on this instrumentation. No other vendor is qualified or authorized to perform these functions.
4. Federal Procurement Precedent Multiple federal agencies including the National Institutes of Environmental Health Sciences (NIEHS), National Cancer Institute (NCI), U.S. Army DEVCOM-SC, and VA VISN 21 have each independently documented Agilent Technologies, Inc. as the sole source for Seahorse XF Analyzer platforms and confirmed that no commercially available equivalent exists.
5. Market Research Market research conducted by NCO 17 confirmed that no other vendor manufactures a live-cell metabolic analysis instrument meeting all technical specifications outlined in the Statement of Work dated June 2026.
OPPORTUNITY FOR COMPETITION / RESPONSE INSTRUCTIONS
This notice is not a request for competitive proposals or quotations. However, all responsible sources that believe they can satisfy this requirement in its entirety are encouraged to submit a written capability statement or quotation to the Contracting Officer no later than July 7, 2026, at 4:00 PM Central Time.
Responses must be submitted in writing and must contain sufficient detail to allow the Government to determine whether the offeror can fully meet the technical requirements specified in the Statement of Work. Capability statements must address each technical specification, including simultaneous OCR/PER measurement, 96-well microplate format, automated compound injection, proprietary software integration, and authorized installation and service capability.
Offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov at the time of response submission and at the time of any potential award. No telephone responses will be accepted. A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government.
If no responsive capability statements or quotations are received by the response deadline, the VA intends to proceed with award to Agilent Technologies, Inc.
POINT OF CONTACT
Ognian D. Ivanov
Contracting Officer
Department of Veterans Affairs
RPO West | NCO 17 | Lab Services Support (LSS)
5441 Babcock Rd., Suite 302, San Antonio, TX 78240
Email: ognian.ivanov@va.gov
NOTE: This notice is being posted in accordance with FAR 5.101 and FAR 13.106-1(b). The Government reserves the right to cancel this notice at any time.
